|
HS Code |
736032 |
| Chemical Name | (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride |
| Cas Number | 959247-81-9 |
| Molecular Formula | C8H11BrN·HCl |
| Molecular Weight | 240.55 g/mol |
| Appearance | White to off-white solid |
| Optical Activity | R-(+)-enantiomer |
| Purity | Typically ≥98% |
| Melting Point | 175-179°C (decomp.) |
| Solubility | Soluble in water, sparingly soluble in ethanol |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Synonyms | (R)-(+)-para-Bromoamphetamine hydrochloride |
| Smiles | CC(N)C1=CC=C(C=C1)Br.Cl |
As an accredited (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the realm of specialty chemicals, (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride stands out for its precision and reliability in research environments. Chemo-pharmaceutical labs often chase compounds that offer clear enantiomeric purity, and this particular molecule meets that demand. You won’t find many materials that combine fine-tuned chirality with a stable crystalline form in quite this way.
Chemists with a background in asymmetric synthesis or those navigating the tricky territory of developing new active pharmaceutical ingredients recognize that small differences in molecular structure can make or break an experiment. (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride offers a well-defined (R)-enantiomer. Its distinct configuration matters in many applications where a single enantiomer brings desired biological activity, reducing unwanted effects associated with racemic mixtures.
The raw appearance gives a hint about its purity and readiness for lab work: fine, off-white crystals, easily handled without caking or clumping, which reflects a well-controlled synthesis and purification. Anyone familiar with handling poorly characterized amines knows how challenging purification can become without this clear appearance.
Choosing between different phenylethylamines can feel routine until you’re after strict selectivity or high reproducibility. In my own work, projects involving stereoselective catalysis become far smoother with reagents like this. Many labs try working with racemates, muddling through difficult separations, yet the (R)-enantiomer here saves time by delivering a defined stereochemistry right out of the bottle. You avoid extra steps—a real boon for those with pressing deadlines or a tight grant schedule.
It is easy enough to find unsubstituted phenylethylamines, but the 4-bromo group makes this molecule more reactive in coupling and derivatization steps. This modification allows researchers to explore new analogs and intermediates not as accessible from plain derivatives or those with less reactive substituents. Comparatively, the hydrochloride salt form grants higher stability and shelf-life than its free base, making stock solutions and storage less of a headache.
Most often, (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride steps into action during the early phase of pharmaceutical discovery, supporting chiral pool syntheses or serving as an advanced intermediate in making optically active molecules. In hands-on chemistry, the ease of weighing and dissolving the hydrochloride version takes the stress out of batch-to-batch variation—a problem that’s caught me off-guard with less stable reagents.
Medicinal chemistry teams invest heavily in molecular frameworks that modulate neurotransmitters. This compound finds its way into pipeline research because its amine group offers a convenient attachment point for creating new CNS-active scaffolds. In certain cases, it acts as a precursor for compounds that probe the central nervous system, with selectivity provided by the (R) stereochemistry. Some teams have reported streamlined development cycles as a result.
And then there’s its role in the synthesis of chiral auxiliaries and ligand libraries. Many students new to chiral chemistry underestimate the benefit of having access to single-enantiomer amines; seasoned chemists see productivity gains by skipping resolution steps. Some biocatalysis projects also start with matched enantiomers to push selectivity in enzyme-catalyzed reactions, where having the “wrong” isomer costs precious time and resources.
Specifications do more than fill out a TDS sheet; they dictate whether a compound lies at the core of a trusted workflow. In the labs where I’ve worked, batch consistency, purity above 98%, and enantiomeric excess north of 99% are not just talking points—they are job requirements. Analytical data, such as chiral HPLC traces, give chemists a sense of security. Still, seeing those clean crystal habits and knowing the salt won’t rapidly pick up moisture means less scrambling to correct for weigh-in errors or degradation during project sprints.
Some competitive products skimp on analytical follow-up, selling material without strong characterization. In contrast, the reliable crystalline hydrochloride form gives repeated, dependable NMR, melting point, and optical rotation measurements. This transparency in how the material behaves assures chemists they are working with a clean, well-behaved starting point. Sigma values in analytical reports are not just comforting, they mean your process chemistry is on more solid ground.
Anyone who has spent a few years in synthesis or discovery chemistry knows the frustration of ordering phenylethylamines and getting unpredictable results. Freebase forms can absorb water, degrade, or deliver inconsistent assay readings. That uncertainty saps project confidence, especially when scaling up or moving from bench to kilo-lab. The hydrochloride salt side-steps these headaches, sparing chemists from late-stage troubleshooting or the classic “why does this batch look different?” dilemma.
Compared to the (S)-enantiomer, the (R)-version unlocks different biological profiles. Every project has a “right” and “wrong” isomer—sometimes, the difference comes down to a handful of nanomoles in screening assays. While racemates have their place in some synthetic explorations, they introduce complexity downstream. Projects calling for direct enantiokey intermediates work best by starting with pure (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride.
Google’s E-E-A-T principles focus on experience, expertise, authoritativeness, and trustworthiness. These values ring true in the lab as well. Real-world chemistry demands attention to detail, willingness to document and question anomalies, and an insistence on reproducibility. Working with well-characterized (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride builds that foundation. I’ve known projects to stumble when colleagues assumed “close enough” would do—much better to lean into rigor, both in selecting input materials and sharing full analytical documentation with collaborators.
Ethical research also calls for an honest look at safety and responsible use. Researchers bear a duty to handle every specialty chemical with proper storage and disposal, following regulatory and institutional safeguards. The hydrochloride version of this compound supports these commitments: lower volatility, reduced dust, and fewer surprises during transfers or solution prep all mean a safer, more predictable lab day.
Producing (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride requires a multi-step chiral synthesis, often involving either enzymatic resolution or asymmetric catalysis. The advanced synthetic strategies behind this product represent years of cumulative knowledge in both academic and industrial process chemistry. By choosing reliable supply partners who invest in in-depth quality control and transparency, researchers tangibly support ongoing improvements.
Getting the right compound on time often drives the pace of innovation in both pharma and materials science. In my own collaborations with teams around the globe, timely access to pure starting materials spurred new ideas and brought projects across the finish line more rapidly. The direct impact? Fewer bottlenecks, smoother QC sign-offs, and fewer “investigation meetings” on unexpected batches. This is not just an anecdotal effect—datasets across the chemical industry back up the claim that robust supply of high-purity specialty intermediates positively shapes timelines and patent filings.
Practicing scientists today expect more than a simple “ship and forget” approach from suppliers. They want full traceability, transparent supply chains, and proof that their inputs came from ethical sources. (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride supplied with detailed CoAs, reliable batch documentation, and responsive technical support fits right into that ecosystem. Projects run smoother when communication is consistent and the supplier backs every shipment with data that stands up to regulatory or peer review scrutiny.
On top of traceability, chemists in academia and industry alike face higher scrutiny over waste generation and safety protocols. Opting for compounds in stable, easy-to-handle salt forms cuts down on accidents and environmental risks. The experience gained here matters outside just one project—it shapes future habits and forms the basis for more responsible, sustainable science.
Rational drug design continues to evolve, and fragments like (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride serve as building blocks for tomorrow’s medicines. In the push for next-generation treatments—targeted therapies, new neuroactive scaffolds, clever diagnostic tracers—having reliable, pure, and well-characterized intermediates remains essential.
Analytical method development also benefits. Precise standards, such as this enantiomerically pure amine, help push new chiral separation techniques and validate emerging NMR, MS, or other QC technologies. Graduate students and postdocs aiming for high-impact publications gain a significant edge by using well-characterized references like this hydrochloride. In reviewing submissions for scientific journals, I’ve valued the clarity that comes from seeing recognizable standards mentioned, giving confidence that results will hold up to real-world replication.
Even small differences in reagent quality influence project outcomes. Take it from direct experience: one off-spec batch sets a project back by weeks or forces tedious troubleshooting. Clear communication with suppliers provides early warnings, avoids costly surprises, and places quality assurance squarely on the agenda. Choosing a compound like (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride—well-supported and documented—shrinks the risk of setbacks.
One option for further improving outcomes lies in forging long-term relationships with trusted suppliers. Purchasing chemicals from untraceable or non-transparent sources can seem convenient at first, yet the problems that arise—variable purity, uncertain stereochemistry, lack of data—outweigh any cost savings. Labs that stick with reputably sourced hydrochloride salts report fewer issues with cross-contamination, shelf instability, or batch failures. The stress saved pays off in research published on time, project milestones met, and talented team members kept motivated by steady progress.
Time on the bench has taught me a healthy skepticism toward “good enough” reagents. In fast-paced discovery work, having pure, well-characterized chiral intermediates like (R)-(+)-1-(4-Bromophenyl)Ethylamine Hydrochloride delivers value far beyond its role as a molecule. Working with this compound reduces headaches, gives more confident results, and backs ambitious research goals. For teams weighing cost against quality, the investment in a strong, stable enantiomer never disappoints. The comfort of knowing every experiment starts on the right foot is something every scientist can appreciate, no matter the field or focus.